new glp 1 coming to market GLP-1 Receptor Agonist Size, Trends and Share Report 2026 GLP-1 Analogues Market Size, Share

however, this trend shifted in 2023 when women instead surpassed men

Every plan is built around you and every result is designed to look like you, just better

It's enough to have a serious conversation with your rheumatologist, especially if you have RA plus excess weight, insulin resistance, or elevated cardiovascular risk

Individuals with diabetes taking semaglutide may be at a 4x greater risk for developing NAION

Many weight loss medications are covered by insurance, such as Wegovy, Foundayo, and Zepbound

GLP BodyGuard's brand-stated positioning - educational tracking, not medical advice, not diagnosis, not treatment - is structurally consistent with what the FDA's 2026 guidance describes as general wellness territory